Marketed in 33 countries across Europe, Latin America, the Middle East, and parts of Asia, Cataflam is an internationally distributed brand of diclofenac, classified within the non-steroidal anti-inflammatory category. For travellers and expatriates, it is one of the more recognisable diclofenac brands encountered on pharmacy shelves outside their home country.
Cataflam is prescribed across a broad span of pain and inflammatory indications, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, neuralgia, backache, bursitis, and symptomatic relief in conditions such as influenza. The full registered indication list is shown in the structured section further down this page, where the recognised uses in each market are detailed.
Because Cataflam is registered across such a varied set of regulatory environments — from Brazil and Ecuador to Indonesia, Belgium, Egypt, and Hungary — packaging, prescription status, and available formulations differ noticeably from one country to another. The same active ingredient, diclofenac, also circulates worldwide under a substantial number of other brand names, both branded and generic, which means the medication a traveller knows as Cataflam at home may appear under an entirely different label abroad.
Other molecules within the non-steroidal anti-inflammatory class are also widely available internationally, though they are not freely interchangeable — choices within the class differ in their clinical positioning, and a pharmacist familiar with the local formulary is the right person to identify regional options. Anyone using Cataflam regularly, or trying to identify a comparable product in an unfamiliar country, should treat that question as a medical one and bring it to a healthcare provider rather than resolving it at the counter.
